Medline Inc.
34.09USD
-0.7900 (-2.26%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MDLN.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| Revenue | 7,685 | 7,352 | 6,886 | 6,644 |
| Cost of Revenue | 5,470 | 5,511 | 4,981 | 4,820 |
| Gross Profit | 2,215 | 1,841 | 1,905 | 1,824 |
| Operating Income | 395 | 422 | 642 | 571 |
| Net Income | 139 | 239 | 329 | 319 |
| EPS (Diluted) | $0.07 | $0.16 | — | — |
Source: SEC filings (EDGAR)